Compare FRAF & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FRAF | SMTI |
|---|---|---|
| Founded | 1906 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 279.0M | 320.2M |
| IPO Year | 1995 | 2008 |
| Metric | FRAF | SMTI |
|---|---|---|
| Price | $63.95 | $35.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 25.4K | ★ 154.6K |
| Earning Date | 10-27-2026 | 11-11-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 88.84 | N/A |
| EPS | ★ 2.94 | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $13.07 |
| Revenue Next Year | $6.58 | $14.23 |
| P/E Ratio | $21.54 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $43.47 | $16.05 |
| 52 Week High | $65.41 | $35.34 |
| Indicator | FRAF | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 63.52 |
| Support Level | $60.34 | $33.99 |
| Resistance Level | $64.44 | $35.34 |
| Average True Range (ATR) | 1.58 | 0.19 |
| MACD | 0.08 | -0.13 |
| Stochastic Oscillator | 81.28 | 52.50 |
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking, and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities, which include accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.